Perceptive Advisors Raises $323 Million Credit Opportunities Fund

10/25/16

Perceptive Advisors LLC, an investment management firm focused on the healthcare sector, today announced the closing of a new fund, the Perceptive Credit Opportunities Fund, that provides private credit to healthcare companies. The Fund and related entities have $323 million in investor commitments and exceeded the $300 million target. The Fund's global investor base includes endowments, family offices, and institutional investors.

The Perceptive Credit Opportunities Fund is focused on providing customized debt financing solutions to innovative healthcare companies across all stages and subsectors, including biopharma, medical devices, diagnostics, life science research and healthcare information technology. The Fund partners with small and medium-sized companies to provide capital ranging from $10 - $50 million per investment. Through prior closings, the Fund has been actively investing in companies.

"We are really thrilled to have this new investment fund dedicated to providing private credit to healthcare companies to fuel innovation and support growth," said Joseph Edelman, Founder and CEO of Perceptive Advisors.

"We are seeing strong interest from healthcare companies seeking minimally dilutive funding for growth opportunities. Our capital base will enable us to invest in attractive opportunities that we are seeing in the market," said Sam Chawla, Portfolio Manager of the Perceptive Credit Opportunities Fund. "We are grateful for the strong support we received from our broad base of limited partners."

About Perceptive Advisors

Founded in 1999 and based in New York, NY, Perceptive Advisors is an investment management firm focused on supporting the progress of the life sciences industry by identifying opportunities and directing financial resources to the most promising technologies in healthcare. For more information about Perceptive, visit www.perceptivelife.com.

Recent Deals

Interested in advertising your deals? Contact Edwin Warfield.